Applications are invited for two Senior Scientists in Bioprocess & Analytical Development to take leading roles in the translation of novel biological drug candidates to the clinic as part of the University of Oxford’s new Biological Process & Analytical Development (BiPAD) team. Initially you will contribute to the ongoing and fast-moving development of improved processes and analytics for global manufacturing of the Oxford COVID-19 vaccine, but we anticipate the role will be broad and varied beyond this. The BiPAD team will aim to provide expert input to GMP process & analytical development for diverse products emerging from the University of Oxford’s world-leading translational research (including other vaccines, monoclonal antibodies, gene therapies, nucleic acid products, cell line development, and other biologicals).